| Literature DB >> 28119486 |
Andreja Erman1, Veronika Križan Hergouth2, Matthew G Blango3, Mojca Kerec Kos4, Matthew A Mulvey3, Peter Veranic1.
Abstract
Uropathogenic Escherichia coli (UPEC), the primary causative agents of urinary tract infections, colonize and invade the epithelial cells of the bladder urothelium. Infection of immature urothelial cells can result in the formation of persistent intracellular reservoirs that are refractory to antibiotic treatments. Previously, we defined a novel therapeutic strategy that used the bladder cell exfoliant chitosan to deplete UPEC reservoirs. However, although a single treatment of chitosan followed by ciprofloxacin administration had a marked effect on reducing UPEC titers within the bladder, this treatment failed to prevent relapsing bacteriuria. We show here that repeated use of chitosan in conjunction with the antibiotic ciprofloxacin completely eradicates UPEC from the urinary tract and prevents the development of relapsing bouts of bacteriuria. In addition, microscopy revealed rapid restoration of bladder integrity following chitosan treatment, indicating that chitosan can be used to effectively combat recalcitrant bladder infections without causing lasting harm to the urothelium.Entities:
Keywords: UPEC; UTI; bacteriuria; chitosan; recurrent bladder infections; urinary tract infection; uropathogenic; urothelium
Mesh:
Substances:
Year: 2017 PMID: 28119486 PMCID: PMC5853829 DOI: 10.1093/infdis/jix023
Source DB: PubMed Journal: J Infect Dis ISSN: 0022-1899 Impact factor: 5.226